DOI 10.1007/s00292-025-01500-3
[Cervical cancer screening in Germany 2020-2022 : An analysis of the first round of screening according to the specifications of the oKFE-RL].
Аннотация
BACKGROUND
In 2020, the Organised Early Cancer Diagnosis Guideline (eKFE-RL) programme was introduced in Germany. Women up to the age of 34 years are entitled to annual cytology-based screening. Women aged 35 years and over are entitled to a combined test (cytology and HPV) every 3 years. An age-related assessment algorithm determines the procedure if there are abnormal findings.
METHOD: A total of 222,851 data were evaluated and analysed from the first round of screening in 2020-2021 according to the oKFE-RL: the prevalence of HPV, its age distribution in general and in HPV-positive findings (n = 10,405), as well as the distribution of HPV 16, 18 and other HPV types, are shown in cervical intraepithelial neoplasia (CIN) lesions. CIN 3 lesions are depicted and compared with the baseline value for 2019.
RESULTS
A threefold increase in CIN 3 compared with 2019 was determined. The peak age for CIN 3 is in women aged 35-39 years. The HPV-positive rate is 8.11 %.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.